TRML logo

Tourmaline Bio, Inc. (TRML) Cash From Financing

Annual CFF:

$161.35M+$4.63M(+2.95%)
December 31, 2024

Summary

  • As of today, TRML annual cash from financing is $161.35 million, with the most recent change of +$4.63 million (+2.95%) on December 31, 2024.
  • During the last 3 years, TRML annual cash from financing has risen by +$23.95 million (+17.43%).
  • TRML annual cash from financing is now at all-time high.

Performance

TRML Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

Quarterly CFF:

$54.00K-$508.00K(-90.39%)
June 30, 2025

Summary

  • As of today, TRML quarterly cash from financing is $54.00 thousand, with the most recent change of -$508.00 thousand (-90.39%) on June 30, 2025.
  • Over the past year, TRML quarterly cash from financing has increased by +$54.00 thousand (+100.00%).
  • TRML quarterly cash from financing is now -99.97% below its all-time high of $161.35 million, reached on March 31, 2024.

Performance

TRML Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

TTM CFF:

$612.00K+$54.00K(+9.68%)
June 30, 2025

Summary

  • As of today, TRML TTM cash from financing is $612.00 thousand, with the most recent change of +$54.00 thousand (+9.68%) on June 30, 2025.
  • Over the past year, TRML TTM cash from financing has dropped by -$225.26 million (-99.73%).
  • TRML TTM cash from financing is now -99.81% below its all-time high of $318.07 million, reached on March 31, 2024.

Performance

TRML TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TRML Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+3.0%+100.0%-99.7%
3Y3 Years+17.4%-31.6%+2140.0%
5Y5 Years+345.7%+125.0%-99.5%

TRML Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+712.8%-100.0%+101.5%-99.8%+9.7%
5Y5-Yearat high+712.8%-100.0%+101.5%-99.8%+2140.0%
All-TimeAll-Timeat high+712.8%-100.0%+101.5%-99.8%+2140.0%

TRML Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
$54.00K(-90.4%)
$612.00K(+9.7%)
Mar 2025
-
$562.00K(>+9900.0%)
$558.00K(-99.7%)
Dec 2024
$161.35M(+3.0%)
-$3000.00(-200.0%)
$161.35M(-29.7%)
Sep 2024
-
-$1000.00(>-9900.0%)
$229.49M(+1.6%)
Jun 2024
-
$0.00(-100.0%)
$225.87M(-29.0%)
Mar 2024
-
$161.35M(+136.8%)
$318.07M(+103.0%)
Dec 2023
$156.72M(+689.5%)
$68.14M(+1980.8%)
$156.72M(+44.8%)
Sep 2023
-
-$3.62M(-103.9%)
$108.25M(-3.3%)
Jun 2023
-
$92.20M(>+9900.0%)
$111.94M(+464.8%)
Mar 2023
-
$0.00(-100.0%)
$19.82M(-0.2%)
Dec 2022
$19.85M
-
-
Dec 2022
-
$19.67M(>+9900.0%)
$19.85M(+3241.8%)
DateAnnualQuarterlyTTM
Sep 2022
-
$73.00K(-7.6%)
$594.00K(+2080.0%)
Jun 2022
-
$79.00K(+163.3%)
-$30.00K(-100.0%)
Mar 2022
-
$30.00K(-92.7%)
$137.41M(+0.0%)
Dec 2021
$137.40M(+4.8%)
$412.00K(+174.8%)
$137.40M(+0.7%)
Sep 2021
-
-$551.00K(-100.4%)
$136.46M(-49.2%)
Jun 2021
-
$137.52M(>+9900.0%)
$268.64M(+104.8%)
Mar 2021
-
$17.00K(+103.2%)
$131.14M(+0.0%)
Dec 2020
$131.12M(+262.2%)
-$524.00K(-100.4%)
$131.12M(-0.4%)
Sep 2020
-
$131.62M(>+9900.0%)
$131.65M(>+9900.0%)
Jun 2020
-
$24.00K(>+9900.0%)
$24.00K(>+9900.0%)
Mar 2020
-
$0.00
$0.00
Dec 2019
$36.20M
-
-

FAQ

  • What is Tourmaline Bio, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. annual cash from financing year-on-year change?
  • What is Tourmaline Bio, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. quarterly cash from financing year-on-year change?
  • What is Tourmaline Bio, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. TTM cash from financing year-on-year change?

What is Tourmaline Bio, Inc. annual cash from financing?

The current annual cash from financing of TRML is $161.35M

What is the all-time high annual cash from financing for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high annual cash from financing is $161.35M

What is Tourmaline Bio, Inc. annual cash from financing year-on-year change?

Over the past year, TRML annual cash from financing has changed by +$4.63M (+2.95%)

What is Tourmaline Bio, Inc. quarterly cash from financing?

The current quarterly cash from financing of TRML is $54.00K

What is the all-time high quarterly cash from financing for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high quarterly cash from financing is $161.35M

What is Tourmaline Bio, Inc. quarterly cash from financing year-on-year change?

Over the past year, TRML quarterly cash from financing has changed by +$54.00K (+100.00%)

What is Tourmaline Bio, Inc. TTM cash from financing?

The current TTM cash from financing of TRML is $612.00K

What is the all-time high TTM cash from financing for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high TTM cash from financing is $318.07M

What is Tourmaline Bio, Inc. TTM cash from financing year-on-year change?

Over the past year, TRML TTM cash from financing has changed by -$225.26M (-99.73%)
On this page